Invention Grant
- Patent Title: Integrin inhibitors for the treatment of eye diseases
- Patent Title (中): 用于治疗眼部疾病的整合素抑制剂
-
Application No.: US11510596Application Date: 2006-08-28
-
Publication No.: US07645736B2Publication Date: 2010-01-12
- Inventor: Hans-Markus Bender , Jutta Haunschild , Ulrich Lang , Matthias Wiesner , Martin Friedlander
- Applicant: Hans-Markus Bender , Jutta Haunschild , Ulrich Lang , Matthias Wiesner , Martin Friedlander
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Millen, White, Zelano, Branigan, P.C.
- Main IPC: A61K38/00
- IPC: A61K38/00

Abstract:
Methods for the treatment of a disease of the eye of a patient comprising injecting into the vitreous body of the eye a composition comprising a therapeutically effective amount of an αvβ3 and/or αvβ5 inhibitor sufficient to inhibit angiogenesis and inhibit neovascularization in the treated eye. The αvβ3 and/or αvβ5 inhibitor being a compound of formula II: as defined herein or a physiologically acceptable salt thereof.
Public/Granted literature
- US20060287225A1 Integrin inhibitors for the treatment of eye diseases Public/Granted day:2006-12-21
Information query
IPC分类: